Articaine or Eugenol: a Study on the Choice of Endodontic Medication in the Emergency Management of Irreversible Pulpitis of a Mature Permanent Tooth
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Pain evolution (decrease or increase the intensity of the pain)
研究概览
简要总结
The objective of the study is to determine which of the two commonly used endodontic medications (Eugenol VS Articaine) is most effective in controlling postoperative pain in irreversible pulpitis of the mature permanent tooth in adults. To do so, an assessment of the pain felt by patients will be carried out a few days apart. The supposed results are that the medications are equivalent in terms of effectiveness on the pain, but could then present different economic arguments
详细描述
In irreversible pulpitis of the mature permanent tooth, the enrolled patients receive endodontic medications (Eugenol or Articaine) in order to determine which one is the more efficient to control the pain.
These patients would have received the same medication without this study. That's why this is an obsevationnal study.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patient, major, affiliated to a social health insurance scheme
- •Patient having agreed to participate in the study
- •Urgent consultant patient for irreversible pulpitis
- •Patient understanding French
排除标准
- •Refusal of the patient to participate in the study
- •Impossibility of performing the surgical procedure
- •Impossibility to give the subject information enlightened (difficulty of understanding ...)
- •Subject under the protection of justice, or under guardianship
- •General contraindication to endodontic treatment in 2 sessions (high risk of infectious endocarditis, for example)
- •Chronic intake of analgesic drugs
结局指标
主要结局
Pain evolution (decrease or increase the intensity of the pain)
时间窗: 7 days
Evolution of pain (using a score of 0 to 10)
次要结局
未报告次要终点